Kemnay Advisory Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-121,573	Closed	-$2.08M	–	38
2021 Q4	$2.08M	Buy	+121,573	New	+$2.08M	0.29%	34